[See also: Semaglutide FAQ ] Semaglutide, sold under the brand name Ozempic, first came on the market for treating diabetes in 2017
A significant proportion of our cohort used dulaglutide (24%) and exenatide (13%), which are less efficacious for weight loss compared with liraglutide and semaglutide [43]
Among patients with type 2 diabetes, GLP-1 use was associated with a 32% lower risk of fracture for those with osteopenia and for those with osteoporosis, as seen in Figure 1
Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, Org E, Wu Y, Li L, Smith JD, Tang WHW, Didonato JA, Lusis AJ, Hazen SL
If patients are not following those directions, it could inhibit proper absorption and affect the efficacy of the medication, she said